Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 739

1.

Acute effects of nicotine and mecamylamine on tobacco withdrawal symptoms, cigarette reward and ad lib smoking.

Rose JE, Behm FM, Westman EC.

Pharmacol Biochem Behav. 2001 Feb;68(2):187-97.

PMID:
11267622
2.

Mecamylamine does not precipitate withdrawal in cigarette smokers.

Eissenberg T, Griffiths RR, Stitzer ML.

Psychopharmacology (Berl). 1996 Oct;127(4):328-36.

PMID:
8923568
3.

Mecamylamine acutely increases human intravenous nicotine self-administration.

Rose JE, Behm FM, Westman EC, Bates JE.

Pharmacol Biochem Behav. 2003 Sep;76(2):307-13.

PMID:
14592683
4.

Nicotine-mecamylamine interactions.

Zevin S, Jacob P 3rd, Benowitz NL.

Clin Pharmacol Ther. 2000 Jul;68(1):58-66.

PMID:
10945316
5.

Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal.

Teneggi V, Tiffany ST, Squassante L, Milleri S, Ziviani L, Bye A.

Psychopharmacology (Berl). 2002 Nov;164(2):177-87.

PMID:
12404080
6.

High-dose transdermal nicotine and naltrexone: effects on nicotine withdrawal, urges, smoking, and effects of smoking.

Rohsenow DJ, Monti PM, Hutchison KE, Swift RM, MacKinnon SV, Sirota AD, Kaplan GB.

Exp Clin Psychopharmacol. 2007 Feb;15(1):81-92.

PMID:
17295587
7.

Extinguishing the rewarding value of smoke cues: pharmacological and behavioral treatments.

Rose JE, Behm FM.

Nicotine Tob Res. 2004 Jun;6(3):523-32.

PMID:
15203786
8.

Cotinine: effects with and without nicotine.

Hatsukami D, Pentel PR, Jensen J, Nelson D, Allen SS, Goldman A, Rafael D.

Psychopharmacology (Berl). 1998 Jan;135(2):141-50.

PMID:
9497019
9.
10.

Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone.

Rose JE, Behm FM, Westman EC, Levin ED, Stein RM, Ripka GV.

Clin Pharmacol Ther. 1994 Jul;56(1):86-99.

PMID:
8033499
11.

Effects of the nicotinic receptor antagonist mecamylamine on ad-lib smoking behavior, topography, and nicotine levels in smokers with and without schizophrenia: a preliminary study.

McKee SA, Weinberger AH, Harrison EL, Coppola S, George TP.

Schizophr Res. 2009 Dec;115(2-3):317-24. doi: 10.1016/j.schres.2009.07.019.

12.

Platelet monoamine oxidase, smoking cessation, and tobacco withdrawal symptoms.

Rose JE, Behm FM, Ramsey C, Ritchie JC Jr.

Nicotine Tob Res. 2001 Nov;3(4):383-90.

PMID:
11694206
13.

Nicotine patches and the subjective effects of cigarette smoking: a pilot study.

Cárdenas L, Busto UE, MacDonald A, Corrigall WA.

Can J Clin Pharmacol. 2002 Winter;9(4):175-82.

PMID:
12584575
14.

Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms.

Sacco KA, Termine A, Seyal A, Dudas MM, Vessicchio JC, Krishnan-Sarin S, Jatlow PI, Wexler BE, George TP.

Arch Gen Psychiatry. 2005 Jun;62(6):649-59.

PMID:
15939842
15.

Nicotine-mecamylamine treatment for smoking cessation: the role of pre-cessation therapy.

Rose JE, Behm FM, Westman EC.

Exp Clin Psychopharmacol. 1998 Aug;6(3):331-43.

PMID:
9725117
16.

Mecamylamine increases nicotine preference and attenuates nicotine discrimination.

Rose JE, Sampson A, Levin ED, Henningfield JE.

Pharmacol Biochem Behav. 1989 Apr;32(4):933-8.

PMID:
2798542
17.

Precessation treatment with nicotine skin patch facilitates smoking cessation.

Rose JE, Behm FM, Westman EC, Kukovich P.

Nicotine Tob Res. 2006 Feb;8(1):89-101.

PMID:
16497603
18.

The influence of transdermal nicotine on tobacco/nicotine abstinence and the effects of a concurrently administered cigarette in women and men.

Kleykamp BA, Jennings JM, Sams C, Weaver MF, Eissenberg T.

Exp Clin Psychopharmacol. 2008 Apr;16(2):99-112. doi: 10.1037/1064-1297.16.2.99.

PMID:
18489014
19.

Delay discounting predicts cigarette smoking in a laboratory model of abstinence reinforcement.

Dallery J, Raiff BR.

Psychopharmacology (Berl). 2007 Mar;190(4):485-96.

PMID:
17205320
20.

Pharmacologic and sensorimotor components of satiation in cigarette smoking.

Rose JE, Behm FM, Westman EC, Bates JE, Salley A.

Pharmacol Biochem Behav. 2003 Sep;76(2):243-50.

PMID:
14592675
Items per page

Supplemental Content

Support Center